76.
Acute exercise exacerbates ischemia-induced diastolic rigor in hypertensive myocardium
Patricia
O
Reger,
Stephen
C
Kolwicz,
Joseph
R
Libonati
SpringerPlus 2012, 1 :46 (2 November 2012)
Abstract | Full text | PDF
77.
“Nonparametric Local Smoothing” is not image registration
Torsten
Rohlfing,
Brian
Avants
BMC Research Notes 2012, 5 :610 (1 November 2012)
Abstract | Full text | PDF | PubMed
78.
Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
Daniel
Polsky,
Machaon
Bonafede,
Jose
A
Suaya
BMC Health Services Research 2012, 12 :379 (31 October 2012)
Abstract | Full text | PDF | PubMed
79.
Cascaded discrimination of normal, abnormal, and confounder classes in histopathology: Gleason grading of prostate cancer
Scott
Doyle,
Michael
D
Feldman,
Natalie
Shih,
John
Tomaszewski,
Anant
Madabhushi
BMC Bioinformatics 2012, 13 :282 (30 October 2012)
Abstract | Full text | PDF | PubMed
80.
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome
Hongshuo
Song,
Jeffrey
W
Pavlicek,
Fangping
Cai,
Tanmoy
Bhattacharya,
Hui
Li,
Shilpa
S
Iyer,
Katharine
J
Bar,
Julie
M
Decker,
Nilu
Goonetilleke,
Michael
KP
Liu,
Anna
Berg,
Bhavna
Hora,
Mark
S
Drinker,
Josh
Eudailey,
Joy
Pickeral,
M
Moody,
Guido
Ferrari,
Andrew
McMichael,
Alan
S
Perelson,
George
M
Shaw,
Beatrice
H
Hahn,
Barton
F
Haynes,
Feng
Gao
Retrovirology 2012, 9 :89 (30 October 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
This paper reveals a broad spectrum of fitness costs to CTL escape mutations in HIV-1l genomes, similar to recent findings reported for neutralizing antibody escape mutations. The findings highlight the extraordinary plasticity and adaptive potential of the HIV-1 genome.
81.
Cost of palliative radiation to the bone for patients with bone metastases secondary to breast or prostate cancer
Gregory
Hess,
Arie
Barlev,
Karen
Chung,
Jerrold
W
Hill,
Eileen
Fonseca
Radiation Oncology 2012, 7 :168 (12 October 2012)
Abstract | Full text | PDF | PubMed
82.
HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells
Rik
Schrijvers,
Sofie
Vets,
Jan
De Rijck,
Nirav
Malani,
Frederic
D
Bushman,
Zeger
Debyser,
Rik
Gijsbers
Retrovirology 2012, 9 :84 (9 October 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
HRP-2 overexpression can compensate for the absence of LEDGF/p75 and indicate that the residual bias in integration targeting observed in the absence of LEDGF/p75 can be ascribed to HRP-2. Knockdown of HRP-2 upon LEDGF/p75 depletion results in a more random HIV-1 integration pattern.
83.
Sex differences in microRNA regulation of gene expression: no smoke, just miRs
Christopher
P
Morgan,
Tracy
L
Bale
Biology of Sex Differences 2012, 3 :22 (26 September 2012)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
84.
Early data from project engage: a program to identify and transition medically hospitalized patients into addictions treatment
Anna
Pecoraro,
Terry
Horton,
Edward
Ewen,
Julie
Becher,
Patricia
A
Wright,
Basha
Silverman,
Patty
McGraw,
George
E
Woody
Addiction Science & Clinical Practice 2012, 7 :20 (25 September 2012)
Abstract | Full text | PDF | PubMed
85.
Expression analyses of the genes harbored by the type 2 diabetes and pediatric BMI associated locus on 10q23
Jianhua
Zhao,
Sandra
Deliard,
Ali
Aziz,
Struan
FA
Grant
BMC Medical Genetics 2012, 13 :89 (24 September 2012)
Abstract | Full text | PDF | PubMed
86.
Shared decision making and behavioral impairment: a national study among children with special health care needs
Alexander
G
Fiks,
Stephanie
Mayne,
A
Localio,
Chris
Feudtner,
Evaline
A
Alessandrini,
James
P
Guevara
BMC Pediatrics 2012, 12 :153 (21 September 2012)
Abstract | Full text | PDF | PubMed
87.
The dendritic cell niche in chronic obstructive pulmonary disease
Angela
Haczku
Respiratory Research 2012, 13 :80 (19 September 2012)
Abstract | Full text | PDF | PubMed
88.
Care of the injured worldwide: trauma still the neglected disease of modern society
Joseph
V
Sakran,
Sarah
E
Greer,
Evan
Werlin,
Maureen
McCunn
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20 :64 (15 September 2012)
Abstract | Full text | PDF | PubMed
89.
E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost
NA
Hutnick,
M
Karuppiah,
J
Pollara,
J
Yan,
DJ
Myles,
K
Broderick,
M
Morrow,
N
Sardasai,
D
Montefiori,
S
Barnett,
G
Ferrari,
DB
Weiner
Retrovirology 2012, 9 (Suppl 2):P364 (13 September 2012)
Full text | PDF
90.
2G12/PGT-binding yeast glycoprotein Gp38 elicits mannose-specific HIV-1 Env cross-reactive antibodies
H
Zhang,
H
Fu,
B
Liu,
RJ
Luallen,
RW
Doms,
DF
Smith,
Y
Geng
Retrovirology 2012, 9 (Suppl 2):P357 (13 September 2012)
Full text | PDF
91.
Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines
J
Yan,
P
Pankhong,
AS
Khan,
NY
Sardesai,
DB
Weiner
Retrovirology 2012, 9 (Suppl 2):P333 (13 September 2012)
Full text | PDF
92.
Increased mucosal CD4+ T-cell activation following vaccination with an adenoviral vector in rhesus macaques
I
Bukh,
R
Calcedo,
S
Roy,
DG
Carnathan,
R
Grant,
SJ
Ratcliffe,
JM
Wilson,
MR
Betts
Retrovirology 2012, 9 (Suppl 2):P267 (13 September 2012)
Full text | PDF
93.
Improved systemic and mucosal antibody responses with a CCR10 ligand adjuvant
N
Hutnick,
DJ
Myles,
A
Ginsberg,
AS
Khan,
J
Yan,
Z
Moldoveanu,
J
Mestecky,
PA
Marx,
M
Kutzler,
DB
Weiner
Retrovirology 2012, 9 (Suppl 2):P203 (13 September 2012)
Full text | PDF
94.
Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
GG
Fouda,
T
Mahlokozera,
K
Rizzolo,
J
Salazar-Gonzalez,
M
Salazar,
G
Learn,
S
Barotra,
M
Sekaran,
E
Russell,
F
Jaeger,
F
Cai,
F
Gao,
B
Hahn,
R
Swanstrom,
S
Meshnick,
V
Mwapasa,
L
Kalilani,
S
Fiscus,
D
Montefiori,
B
Haynes,
J
Kwiek,
M
Alam,
S
Permar
Retrovirology 2012, 9 (Suppl 2):P148 (13 September 2012)
Full text | PDF
95.
Incident cases characterization and deep sequencing provide new insight into multiplicity of infection and HIV evolution in very early acute infection
G
Kijak,
E
Sanders-Buell,
M
Rolland,
H
Li,
A
Bates,
M
Bose,
A
O'Sullivan,
L
Eller,
R
O'Connell,
G
Shaw,
N
Michael,
J
Kim,
M
Robb,
S
Tovanabutra
Retrovirology 2012, 9 (Suppl 2):P143 (13 September 2012)
Full text | PDF
96.
First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
JD
Fuchs,
I
Frank,
N
Kochar,
M
Elizaga,
M
Allen,
D
Carter,
N
Frahm,
SA
Kalams,
M
Mulligan,
R
Sheets,
M
Pensiero,
D
Clarke,
J
Eldridge
Retrovirology 2012, 9 (Suppl 2):P134 (13 September 2012)
Full text | PDF
97.
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)
B
Koblin,
B
Metch,
C
Morgan,
R
Novak,
E
Swann,
D
Metzger,
D
Lucy,
D
Dunbar,
P
Graham,
T
Madenwald,
G
Escamia,
I
Frank
Retrovirology 2012, 9 (Suppl 2):P123 (13 September 2012)
Full text | PDF
98.
Using an internet consumer marketing strategy to reach men who have sex with men for participation in a preventive HIV vaccine clinical trial
CD
Voytek,
KT
Jones,
BL
Curtis,
DT
Fiore,
D
Dunbar,
I
Frank,
DS
Metzger,
Retrovirology 2012, 9 (Suppl 2):P119 (13 September 2012)
Full text | PDF
99.
DNA vaccines expressing conserved elements provide potent and broad immune responses
GN
Pavlakis,
V
Kulkarni,
A
Valentin,
M
Rosati,
NY
Sardesai,
B
Mothe,
C
Brander,
S
LeGall,
DB
Weiner,
M
Rolland,
JI
Mullins,
BK
Felber
Retrovirology 2012, 9 (Suppl 2):O67 (13 September 2012)
Full text | PDF
100.
Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection
H
Hu,
M
Nau,
P
Ehrenberg,
A
Chenine,
Z
Daye,
Z
Wei,
N
Michael,
M
Vahey,
J
Kim,
M
Marovich,
S
Ratto-Kim
Retrovirology 2012, 9 (Suppl 2):O46 (13 September 2012)
Full text | PDF